Enhanced use of gaze cue in a face-following task after brief trial experience in individuals with autism spectrum disorder.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 05 2021
Historique:
received: 29 01 2020
accepted: 07 05 2021
entrez: 28 5 2021
pubmed: 29 5 2021
medline: 9 11 2021
Statut: epublish

Résumé

Eye movements toward sequentially presented face images with or without gaze cues were recorded to investigate whether those with ASD, in comparison to their typically developing (TD) peers, could prospectively perform the task according to gaze cues. Line-drawn face images were sequentially presented for one second each on a laptop PC display, and the face images shifted from side-to-side and up-and-down. In the gaze cue condition, the gaze of the face image was directed to the position where the next face would be presented. Although the participants with ASD looked less at the eye area of the face image than their TD peers, they could perform comparable smooth gaze shift to the gaze cue of the face image in the gaze cue condition. This appropriate gaze shift in the ASD group was more evident in the second half of trials in than in the first half, as revealed by the mean proportion of fixation time in the eye area to valid gaze data in the early phase (during face image presentation) and the time to first fixation on the eye area. These results suggest that individuals with ASD may benefit from the short-period trial experiment by enhancing the usage of gaze cue.

Identifiants

pubmed: 34045501
doi: 10.1038/s41598-021-90230-6
pii: 10.1038/s41598-021-90230-6
pmc: PMC8160015
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11240

Références

Neurosci Biobehav Rev. 2017 Mar;74(Pt A):98-114
pubmed: 28093239
Curr Dir Psychol Sci. 2007 Oct 1;16(5):269-274
pubmed: 19343102
Dev Psychopathol. 2008 Winter;20(1):79-97
pubmed: 18211729
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15220-5
pubmed: 25288765
Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17825-30
pubmed: 17965234
Psychol Med. 1981 Feb;11(1):115-29
pubmed: 7208735
Neuropsychologia. 1993 Sep;31(9):989-98
pubmed: 8232855
Neuropsychologia. 1971 Mar;9(1):97-113
pubmed: 5146491
Dev Psychol. 2004 Mar;40(2):271-83
pubmed: 14979766
J Autism Dev Disord. 2001 Feb;31(1):5-17
pubmed: 11439754
Proc Biol Sci. 2010 Oct 7;277(1696):2935-43
pubmed: 20484237
J Autism Dev Disord. 1979 Mar;9(1):11-29
pubmed: 155684
Biol Lett. 2010 Jun 23;6(3):375-8
pubmed: 20031980
Curr Biol. 2014 Jan 6;24(1):R30-R31
pubmed: 24405675
Br J Psychol. 2005 Feb;96(Pt 1):95-114
pubmed: 15826326
J Int Neuropsychol Soc. 2008 Nov;14(6):947-55
pubmed: 18954475
Child Adolesc Ment Health. 2014 Sep;19(3):163-170
pubmed: 32878369
J Autism Dev Disord. 2006 May;36(4):517-25
pubmed: 16555137
Neurosci Lett. 2003 Sep 4;348(1):17-20
pubmed: 12893415
Am J Psychiatry. 2002 Jun;159(6):895-908
pubmed: 12042174
Neurosci Biobehav Rev. 2016 Apr;63:98-105
pubmed: 26855233
Neuropsychologia. 2008 Sep;46(11):2855-60
pubmed: 18561959
J Exp Child Psychol. 2010 Jan-Feb;105(1-2):20-37
pubmed: 19906386
Neuropsychologia. 2009 Jan;47(1):248-57
pubmed: 18706434
Soc Cogn Affect Neurosci. 2006 Dec;1(3):194-202
pubmed: 18985106
Annu Rev Neurosci. 2005;28:109-26
pubmed: 16033325
Neuroreport. 1999 Nov 8;10(16):3443-7
pubmed: 10599859
Neurosci Biobehav Rev. 2009 Sep;33(8):1204-14
pubmed: 19538990
Front Hum Neurosci. 2018 Oct 23;12:430
pubmed: 30405382
J Autism Dev Disord. 2006 Jan;36(1):5-25
pubmed: 16450045
Nat Neurosci. 2005 Apr;8(4):519-26
pubmed: 15750588
J Autism Dev Disord. 2002 Aug;32(4):249-61
pubmed: 12199131
J Autism Dev Disord. 2005 Jun;35(3):267-77
pubmed: 16119468
Exp Brain Res. 2009 Jan;192(3):521-5
pubmed: 18839160
Nat Neurosci. 2009 Aug;12(8):970-2
pubmed: 19578379
Shinrigaku Kenkyu. 2004 Apr;75(1):78-84
pubmed: 15724518
Neurosci Biobehav Rev. 2014 May;42:279-97
pubmed: 24694721
J Child Psychol Psychiatry. 2004 Mar;45(3):445-58
pubmed: 15055365
Trends Neurosci. 1991 Oct;14(10):433-8
pubmed: 1722361
Neurosci Biobehav Rev. 2009 Jun;33(6):843-63
pubmed: 19428496

Auteurs

Takao Fukui (T)

Department of Rehabilitation for Brain Functions, Research Institute, National Rehabilitation Center for Persons with Disabilities, 4-1 Namiki, Tokorozawa, Saitama, 359-8555, Japan. takao-fukui@tmu.ac.jp.
Faculty of Systems Design, Tokyo Metropolitan University, 6-6 Asahigaoka, Hino, Tokyo, 191-0065, Japan. takao-fukui@tmu.ac.jp.

Mrinmoy Chakrabarty (M)

Department of Rehabilitation for Brain Functions, Research Institute, National Rehabilitation Center for Persons with Disabilities, 4-1 Namiki, Tokorozawa, Saitama, 359-8555, Japan.
Department of Social Sciences and Humanities, Indraprastha Institute of Information Technology Delhi, New Delhi, India.

Misako Sano (M)

Department of Rehabilitation for Brain Functions, Research Institute, National Rehabilitation Center for Persons with Disabilities, 4-1 Namiki, Tokorozawa, Saitama, 359-8555, Japan.
Information and Support Center for the Persons with Developmental Disabilities, National Rehabilitation Center for Persons with Disabilities, Tokorozawa, Japan.
Occupational Therapy Sciences, Department of Integrated Health Sciences, Graduate School of Medicine, Nagoya University, Nagoya, Japan.

Ari Tanaka (A)

Department of Rehabilitation for Brain Functions, Research Institute, National Rehabilitation Center for Persons with Disabilities, 4-1 Namiki, Tokorozawa, Saitama, 359-8555, Japan.

Mayuko Suzuki (M)

Department of Medical Treatment III (Pediatric and Child Psychiatric Section), Hospital, National Rehabilitation Center for Persons with Disabilities, Tokorozawa, Japan.

Sooyung Kim (S)

Department of Medical Treatment III (Pediatric and Child Psychiatric Section), Hospital, National Rehabilitation Center for Persons with Disabilities, Tokorozawa, Japan.

Hiromi Agarie (H)

Department of Medical Treatment III (Pediatric and Child Psychiatric Section), Hospital, National Rehabilitation Center for Persons with Disabilities, Tokorozawa, Japan.

Reiko Fukatsu (R)

Department of Rehabilitation for Brain Functions, Research Institute, National Rehabilitation Center for Persons with Disabilities, 4-1 Namiki, Tokorozawa, Saitama, 359-8555, Japan.
Department of Medical Treatment III (Pediatric and Child Psychiatric Section), Hospital, National Rehabilitation Center for Persons with Disabilities, Tokorozawa, Japan.

Kengo Nishimaki (K)

Information and Support Center for the Persons with Developmental Disabilities, National Rehabilitation Center for Persons with Disabilities, Tokorozawa, Japan.
Department of Medical Treatment III (Pediatric and Child Psychiatric Section), Hospital, National Rehabilitation Center for Persons with Disabilities, Tokorozawa, Japan.

Yasoichi Nakajima (Y)

Department of Rehabilitation for Brain Functions, Research Institute, National Rehabilitation Center for Persons with Disabilities, 4-1 Namiki, Tokorozawa, Saitama, 359-8555, Japan.
National Rehabilitation Center for Persons with Disabilities, Tokorozawa, Japan.
Community Health Care Research Center, Nagano University of Health and Medicine, Nagano, Japan.

Makoto Wada (M)

Department of Rehabilitation for Brain Functions, Research Institute, National Rehabilitation Center for Persons with Disabilities, 4-1 Namiki, Tokorozawa, Saitama, 359-8555, Japan. wada-makoto@rehab.go.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH